NCT04778592

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 149 (actual)
• Sponsor: Eliem Therapeutics (UK) Ltd. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain

Detailed description

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain

Conditions

• Lumbosacral Radiculopathy

Interventions

Type	Name	Description
DRUG	ETX-018810	Study Drug
DRUG	Placebo	Placebo

Timeline

• Start date: 2021-01-19
• Primary completion: 2022-05-16
• Completion: 2022-05-25
• First posted: 2021-03-03
• Last updated: 2023-11-07
• Results posted: 2023-06-06

Locations

24 sites across 1 country: United States

Regulatory

• FDA-regulated drug study